It looks like you're new here. If you want to get involved, click one of these buttons!
The consensus is that U.S. equities will deliver strong performance as the economy recovers, and that higher inflation will drive rising interest rates. All of that is wrong, according to David Rosenberg.
The Toronto-based Rosenberg started his own economic consulting firm in January 2020, Rosenberg Research & Associates, after working a decade as chief economist and strategist at Gluskin Sheff & Associates. He was the opening speaker at this year’s Strategic Investment Conference, hosted by John Mauldin.
Before you place too much weight on Rosenberg’s analysis, recall that he delivered the opening keynote at this conference last year, when he proclaimed that U.S. equity market bulls were in “fantasyland.” He was wrong. The return for the S&P 500 for the last year was 56.25%.
The “fiscal juice” from stimulus checks and the re-opening of the economy are outstripping supply, creating temporary inflation. Supply will catch up when demand subsides as the effect from the stimulus wanes, according to Rosenberg. That will happen before the end of the year.
When the effect of stimulus checks expired last year, GDP declined by 2.5%. We will see a repeat of that this year, according to Rosenberg.

Don’t forget that selling is free at Fidelity whereas it costs $20 to sell. There are other subtle differences. Institutional shares of Pimco funds require $25K while $1M at other brokerages.But automatic investing is available at Fidelity, $5/transaction, and you can stop after one transaction. One could purchase OSTIX at Vanguard ($20) or Merrill Edge ($19.95), transfer it in kind to Fidelity (no transfer fee), and continue investing there.
If you're not expecting to hold for an extended period of time, and you're investing relatively small amounts, that could make sense. Though you'll have to hold for 60 days at Vanguard to avoid a $50 redemption fee.I started a position in ATPAX at Vanguard (ntf, $1,000 minimum) For me the fund seems to have similar risk characteristics to OSTIX with the advantage of being sold ntf.
It might be, if the text in Zacks' column preceding the excerpted conclusion had demonstrated clear thinking or basic understanding of metrics.FWIW, Zack's summary on OSTIX, with the last excerpted statement perhaps being the most important:
https://finance.yahoo.com/news/ostix-strong-bond-fund-now-110011455.html
Given that the R² of OSTIX with respect to a broad market index of fixed income securities is virtually zero (0.02 as of June 30), the reported beta means nothing.OSTIX carries a beta of 0.21, meaning that the fund is less volatile than a broad market index of fixed income securities.
Given two funds identical aside from cost, is the cheaper fund really only likely to outperform the more expensive one? Under what conditions, all things being equal, might the higher cost product outperform?a lower cost product will likely outperform its otherwise identical counterpart, all things being equal.
It appears that Zacks is equating how expensive a fund is solely with its ER. Otherwise it would note that since some other funds have loads, OSTIX is less expensive than (many of) its peers, all in, when you consider operating costs (ER) and purchase costs (loads).In terms of fees, OSTIX is a no load fund. It has an expense ratio of 0.86% compared to the category average of 0.85%. OSTIX is actually more expensive than its peers when you consider factors like cost.

© 2015 Mutual Fund Observer. All rights reserved.
© 2015 Mutual Fund Observer. All rights reserved. Powered by Vanilla